Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

Presentation TCT 2025

MCS Complications: I Wish I Didn’t….

Presenter: William O'Neill

October 28, 2025

Presentation TCT 2025

This All Sounds Great - How Do I Get My Hospital to Agree?

Presenter: William O'Neill

October 28, 2025

Presentation TCT 2023

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

Presenter: William O'Neill

October 24, 2023

Presentation TCT 2023

Introduction

Presenter: William O'Neill

October 24, 2023

News Conference News TCT 2021

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

Caitlin E. Cox

November 09, 2021

Presentation TCT 2021

Pro: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

Presenter: William W. O'Neill

November 05, 2021

Presentation TCT 2021

Ongoing/Planned Cardiogenic Shock Trials in the US

Presenter: William O'Neill

November 05, 2021

Presentation TCT 2021

Real World Evidence leading to RECOVER IV

Presenter: William O'Neill

November 04, 2021

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

Presentation TCT 2019

Acute Cardiogenic Shock: The Number One Unresolved Challenge in Cardiovascular Disease

Presenter: William O'Neill

September 27, 2019

Presentation TCT 2019

Current Landscape and Future Directions: Percutaneous Ventricular Assist Devices

Presenter: William O'Neill

September 25, 2019

Presentation TCT 2018

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Presenter: Jonathan M. Hill, E. Magnus Ohman, William W. O'Neill

September 22, 2018

Presentation TCT 2018

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, William W. O'Neill

September 22, 2018

Presentation TCT 2018

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

Presenter: William W. O'Neill

September 21, 2018

Presentation TCT 2016

The Impella Family of Devices: Utility of Different Tools for Different Conditions

Presenter: David E. Kandzari, Navin K. Kapur, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Staying in Medicine: Potential Options

Presenter: David O. Williams, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Presenter: Ulrich P. Jorde, William W. O'Neill, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

The Role of Right Ventricular and Biventricular Support in CHIP and Shock Cases

Presenter: Ulrich P. Jorde, William W. O'Neill, Sanjog Kalra

October 31, 2016

Advertisement

MCS Complications: I Wish I Didn’t….

This All Sounds Great - How Do I Get My Hospital to Agree?

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

Introduction

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

Pro: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

Ongoing/Planned Cardiogenic Shock Trials in the US

Real World Evidence leading to RECOVER IV

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Acute Cardiogenic Shock: The Number One Unresolved Challenge in Cardiovascular Disease

Current Landscape and Future Directions: Percutaneous Ventricular Assist Devices

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

The Impella Family of Devices: Utility of Different Tools for Different Conditions

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Staying in Medicine: Potential Options

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

The Role of Right Ventricular and Biventricular Support in CHIP and Shock Cases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content